Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents

Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis, and cell cycle arrest in cancer cells. Recently, their use has been clinically validated in cancer patients resultin...

Full description

Saved in:
Bibliographic Details
Published inCurrent medicinal chemistry
Main Authors Cappellacci, Loredana, Perinelli, Diego R, Maggi, Filippo, Grifantini, Mario, Petrelli, Riccardo
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2020
Subjects
Online AccessGet more information

Cover

Loading…